• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围剿艾滋病毒:利用选择性压力之间的相互作用

Cornering HIV: taking advantage of interactions between selective pressures.

作者信息

Avila-Ríos S, Reyes-Terán G, Espinosa E

机构信息

Center for Infectious Diseases Research, National Institute of Respiratory Diseases, Calzada de Tlalpan 4502, CP 14080 Mexico City, Mexico.

出版信息

Med Hypotheses. 2007;69(2):422-31. doi: 10.1016/j.mehy.2006.12.012. Epub 2007 Feb 5.

DOI:10.1016/j.mehy.2006.12.012
PMID:17280799
Abstract

Adaptive immune responses, cellular restrictive factors and antiretroviral drugs, target multiple regions in the Human Immunodeficiency Virus (HIV) proteome, imposing diverse pressures to viral adaptation. However, the virus is remarkably able to escape from these pressures as mutations are selected. In many cases these mutants have diminished viral fitness. We propose that the concerted action of strategically placed agents and pressures in a host can limit HIV variation capacity while inhibiting its replication. These mechanisms would corner HIV by selecting conflicting adaptive mutations, each having a disadvantage in face of another selective pressure. This would keep the virus unable to efficiently escape the suppressive effects of selective pressures. Cornering between antiretroviral drugs and cytotoxic T lymphocytes may explain recent observations, and can be predicted and used in viral control strategies. This idea can be extended to numerous other identified sites in the viral genome that confer selective pressures. We describe these other sites and how they could be induced to interact in prophylactic or therapeutic cornering strategies, as well as their experimental verifications. Cornering would control HIV infection better than current strategies, focused on few, albeit important, sites in the HIV genome.

摘要

适应性免疫反应、细胞限制性因子和抗逆转录病毒药物靶向人类免疫缺陷病毒(HIV)蛋白质组中的多个区域,给病毒适应性带来多种压力。然而,随着突变的产生,病毒能够显著地逃避这些压力。在许多情况下,这些突变体的病毒适应性有所降低。我们提出,宿主中策略性放置的因子和压力的协同作用可以在抑制HIV复制的同时限制其变异能力。这些机制将通过选择相互冲突的适应性突变来使HIV陷入困境,每个突变在面对另一种选择压力时都处于劣势。这将使病毒无法有效逃避选择压力的抑制作用。抗逆转录病毒药物和细胞毒性T淋巴细胞之间的“围剿”可能解释了最近的观察结果,并且可以在病毒控制策略中进行预测和应用。这个想法可以扩展到病毒基因组中其他许多产生选择压力的位点。我们描述了这些其他位点,以及它们如何在预防性或治疗性“围剿”策略中相互作用,以及它们的实验验证。“围剿”将比目前聚焦于HIV基因组中少数(尽管很重要)位点的策略更好地控制HIV感染。

相似文献

1
Cornering HIV: taking advantage of interactions between selective pressures.围剿艾滋病毒:利用选择性压力之间的相互作用
Med Hypotheses. 2007;69(2):422-31. doi: 10.1016/j.mehy.2006.12.012. Epub 2007 Feb 5.
2
[Finding the traces of the HIV selection].[寻找HIV选择的踪迹]
Rev Latinoam Microbiol. 2006 Apr-Jun;48(2):84-90.
3
Drug resistance mutations and the cellular immune response: a valuable synergy for the development of novel immune therapies.耐药性突变与细胞免疫反应:新型免疫疗法开发中的宝贵协同作用。
Curr Opin HIV AIDS. 2007 Mar;2(2):116-22. doi: 10.1097/COH.0b013e3280287a4d.
4
Mutation and control of the human immunodeficiency virus.人类免疫缺陷病毒的突变与控制
Math Biosci. 2008 Jun;213(2):93-102. doi: 10.1016/j.mbs.2008.03.002. Epub 2008 Mar 20.
5
The host environment drives HIV-1 fitness.宿主环境影响HIV-1的适应性。
Rev Med Virol. 2005 Jul-Aug;15(4):219-33. doi: 10.1002/rmv.472.
6
HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.HIV-1逆转录酶抑制剂耐药性突变与适应性:临床及体外研究视角
Virus Res. 2008 Jun;134(1-2):104-23. doi: 10.1016/j.virusres.2007.12.021. Epub 2008 Mar 4.
7
Human immunodeficiency virus reservoir might be actively eradicated as residual malignant cells by cytotoxic chemotherapy.人类免疫缺陷病毒储存库可能会像残留的恶性细胞一样被细胞毒性化疗积极清除。
Med Hypotheses. 2004;62(3):358-63. doi: 10.1016/j.mehy.2003.10.012.
8
Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.高效抗逆转录病毒疗法对病毒复制的抑制作用不会影响HIV特异性CD8(+) T细胞的功能特征。
Eur J Immunol. 2008 Jun;38(6):1548-58. doi: 10.1002/eji.200738054.
9
Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy.人类免疫缺陷病毒控制者:在无抗逆转录病毒治疗情况下持久控制病毒的机制
Immunity. 2007 Sep;27(3):406-16. doi: 10.1016/j.immuni.2007.08.010.
10
Host genetic factors that control immune responses to retrovirus infections.控制对逆转录病毒感染免疫反应的宿主遗传因素。
Vaccine. 2008 Jun 6;26(24):2981-96. doi: 10.1016/j.vaccine.2008.01.004. Epub 2008 Jan 22.

引用本文的文献

1
Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals.在初治的HIV感染个体中鉴定含有耐药突变的免疫原性细胞毒性T淋巴细胞表位
PLoS One. 2016 Jan 25;11(1):e0147571. doi: 10.1371/journal.pone.0147571. eCollection 2016.
2
Evolutionary dynamics of HIV at multiple spatial and temporal scales.HIV 在多个时空尺度上的进化动态。
J Mol Med (Berl). 2012 May;90(5):543-61. doi: 10.1007/s00109-012-0892-1. Epub 2012 May 3.
3
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.
MRKAd5 gag 1型人类免疫缺陷病毒疫苗在全球健康成年人1期研究中的安全性和免疫原性。
AIDS Res Hum Retroviruses. 2011 May;27(5):557-567. doi: 10.1089/AID.2010.0151. Epub 2010 Nov 23.
4
Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study.墨西哥队列中HLA介导的HIV进化的独特特征:一项比较研究。
Retrovirology. 2009 Aug 10;6:72. doi: 10.1186/1742-4690-6-72.